87831060 - AVELAS

Information

• Trademark
• 87831060

• Source

• Serial Number

  87831060

• Registration Number

  5589699

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 12, 2018
  6 years ago

• Registration Date

  October 23, 2018
  5 years ago

• Transaction Date

  October 23, 2023
  7 months ago

• Status Date

  October 23, 2018
  5 years ago

• Published for Opposition Date

  August 07, 2018
  5 years ago

• Location Date

  October 23, 2018
  5 years ago

• First Use Anywhere Date

  April 01, 2015
  9 years ago

• First Use In Commerce Date

  April 01, 2015
  9 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ALI, STEPHANIE MARIE

• Attorney Docket Number

  39088-M1001

  Attorney Name

  Chelsea E. Carbone

  Law Office Assigned Location Code

  L90

• Owners

  • AVELAS BIOSCIENCES, INC.

Case File Statements

• GS0051: Pharmaceuticals for the treatment of cancer; pharmaceuticals for use in the fields of biotechnology and oncology; pharmaceutical products for intraoperative tumor detection, namely, an intravenously administered in vivo fluorescent protease-activatable peptide for the purpose of detecting, marking, targeting, and diagnosing cancer; pharmaceuticals, namely, activatable cell-penetrating peptides (ACPPs) and fluorescence, for the purpose of enabling image-guided surgery in the field of oncology; pharmaceutical preparations, namely, a drug delivery platform involving activatable cell-penetrating peptides (ACPPs); a drug delivery platform utilizing enzyme activation; drug delivery agents, namely, activatable cell-penetrating peptides (ACPPs) or other enzyme mediated mechanism using pathological enzymatic activity to selectively deliver imaging cargo to target tissue; pharmaceuticals to enable systemic delivery of cell-penetrating peptides (CPP) and associated cargo to cancer cells for surgical applications; pharmaceuticals preparations for fluorescence image-guided surgery
• GS0421: Biotechnology research; oncology research; research and development in the biotechnology and oncology fields; development of new technology in the field of biotechnology to enable systemic delivery of cell-penetrating peptides (CPP) and associated cargo to cancer cells; development of new biotechnology, namely, using activatable cell-penetrating peptides (ACPPs) or other enzyme mediated mechanism for surgical and therapeutic applications for cancer patients; development of new biotechnology in the field of oncology for the purpose of delivering a fluorescent, cancer-illuminating probe to detect cancer tissue; development of new biotechnology for intraoperative tumor detection; biotechnology research in connection with developing an intravenously administered in vivo fluorescent protease-activatable peptide for the purpose of detecting, marking, targeting, and diagnosing cancer; conducting clinical trials in the field of biotechnology; clinical research in the field of oncology, namely, cancer surgery and therapeutic intervention; conducting research and clinical trials relating to activatable cell-penetrating peptides (ACPPs) and fluorescence image-guided surgery in the field of oncology; medical research services in the field of cancer

Case File Event Statements

• 10/23/2023 - 7 months ago

  9 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 10/23/2018 - 5 years ago

  8 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/7/2018 - 5 years ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/7/2018 - 5 years ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/18/2018 - 5 years ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/29/2018 - 5 years ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/22/2018 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/19/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/15/2018 - 6 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP